Image

2025 UICMEW | January 22, 2025 Pre-Test

UICMEW | Pre-Test Session 2
Name
Name
First
Last
1. Which of the following is a key benefit of integrating multidisciplinary approaches in managing breast and gynecological cancers?
2. Which of the following advancements is essential for improving outcomes in renal and urothelial cancers?
3. Which of the following is critical for the effective integration of newly approved therapies into clinical practice?
4. What is the importance of precision medicine in managing prostate cancer, as discussed in Dr. Mohammad Atiq’s session?
5. Why is education on new diagnostics and treatments in renal, urothelial, and prostate cancers critical for oncology clinicians?
6. A 62-year-old male with a history of smoking and hypertension presents with hematuria and weight loss. Imaging reveals a mass in the left kidney consistent with renal cell carcinoma. Genetic testing identifies a mutation in the VHL gene. Based on recent advancements in precision medicine, what would be the most appropriate initial treatment strategy?